Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03007545

Ligand	Ligand name	Chain	PDB	Tanimoto
CTX	(Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N-DIMETHYLETHANAMINE	A,B,C	1YA4	0.71
5RM	(5R)-5-(4-methoxy-3-propoxyphenyl)-5-methyl-1,3-oxazolidin-2-one	A,B	1XM6	0.7
ANM	ANISOMYCIN	1,2,4,A,B,C,D,E,J,K,L,M,N,O,P,R,S,T,U,V,Z	1K73	0.71
ANM	ANISOMYCIN	0,1,3,9,A,B,C,F,H,J,K,L,M,N,O,Q,R,S,T,U,Y,Z	3CC4	0.71
2TN	2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE	A	2OTF	0.75
2TN	2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE	A	2NUV	0.75
2TN	2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE	A	2OUB	0.75
SFX	(3S)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine	A	3GWW	0.73
CMZ	(2S)-1-(2,5-dimethylphenoxy)-3-morpholin-4-ylpropan-2-ol	A	2OF0	0.7
NXN	2-(2,4-DICHLORO-PHENOXY)-N-(2-MERCAPTO-ETHYL)-ACETAMIDE	A,B	1SHJ	0.8
RFX	(3R)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine	A	3GWV	0.73
DRS	(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid	A,B	3BXS	0.72
DRR		A,B	3BXR	0.7
PNV	(2S,5R,6R)-3,3-DIMETHYL-7-OXO-6-(2-PHENOXYACETAMIDO)-4-THIA-1- AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID	A,C	2Z71	0.72
PNV	(2S,5R,6R)-3,3-DIMETHYL-7-OXO-6-(2-PHENOXYACETAMIDO)-4-THIA-1- AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID	A	2EX9	0.72
505	(2R)-1-(2,6-dimethylphenoxy)propan-2-amine	A	2VIN	0.74
ZHH	2-(4-METHOXYPHENYL)ETHANAMINE	D,H	2HKR	0.71
PL7	(2E)-2-({(2S)-2-CARBOXY-2-[(PHENOXYACETYL)AMINO]ETHOXY}IMINO)PENTANEDIOIC ACID	A	2JCH	0.76
Y12	4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP-1-EN-1-YL}-1,2-PHENYLENE DIACETATE	A	2EW5	0.72
GMN	2,2',2"-[1,2,3-BENZENE-TRIYLTRIS(OXY)]TRIS[N,N,N-TRIETHYLETHANAMINIUM]	A,B	1N5M	0.74
4SR	(4S)-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]PYRROLIDIN-2-ONE	A,B	1XN0	0.7
P14	N-[2-(2-{[(4-{[AMINO(IMINO)METHYL]AMINO}BUTYL)AMINO]METHYL}-4-METHOXYPHENOXY)ETHYL]GUANIDINE	B	1UUD	0.71
ABY	N-(4-AMINOBUTANOYL)-S-(4-METHOXYBENZYL)-L-CYSTEINYLGLYCINE	A,B	1PL2	0.7
ABY	N-(4-AMINOBUTANOYL)-S-(4-METHOXYBENZYL)-L-CYSTEINYLGLYCINE	A,B	1PL1	0.7
N4E	N-(4-ethoxyphenyl)acetamide	A,B,C,D	3EBS	0.74
ROL	ROLIPRAM	A,B,C,D	1OYN	0.7
ROL	ROLIPRAM	A,B	1XMY	0.7
ROL	ROLIPRAM	A,B,C,D	1Q9M	0.7
ROL	ROLIPRAM	A,B	1RO6	0.7
ROL	ROLIPRAM	A,B	1XN0	0.7
ROL	ROLIPRAM	A,B	1TBB	0.7
NN4	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	A,B,C,D,E,F,G,H	2IRW	0.73
PFD	5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE	A,B	1YOU	0.73
MO9	(1R)-2-[(CYANOMETHYL)AMINO]-1-({[2-(DIFLUOROMETHOXY)BENZYL]SULFONYL}METHYL)-2-OXOETHYL MORPHOLINE-4-CARBOXYLATE	A,B	2G7Y	0.7
TAX	(Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N-DIMETHYLETHANAMINIUM	A	1FJ5	0.75
283	(3S)-1-{[4-(BUT-2-YN-1-YLOXY)PHENYL]SULFONYL}PYRROLIDINE-3-THIOL	A	2OI0	0.7